Vous avez cherché: adcs (Slovaque - Anglais)

adcs-adl
cgic and adcs-adl

adcs- cgic exelon
adcs- cgic exelon

zhoršenia adcs-cgic a
with no worsening on adcs-

hodnota p oproti placebu adcs- cgic
28.6 ± 9.9 1.0 ± 6.8

pozitívne zmeny adcs-adl poukazujú na zlepšenie.
positive adcs-adl changes indicate improvement.

skóre adcs- cgic < 4 poukazujú na zlepšenie.
adcs-cgic scores < 4 indicate improvement.

priemerné skóre ± sd hodnota p oproti placebu adcs- adl
mean score ± sd p-value versus placebo adcs-adl

zlepšenie adas-cog najmenej o 4 body bez zhoršenia adcs-cgic a adcs-adl
at least 4 points improvement on adas-cog with no worsening on adcs- cgic and adcs-adl

skóre adcs-iadl: pozitívny rozdiel dlsm ukazuje väčšie zlepšenie pri exelone 15 cm2 v porovnaní s exelonom 10 cm2.
adcs-iadl scores: a positive difference in dlsm indicates greater improvement in exelon 15 cm2 as compared to exelon 10 cm2.

itt- locf populácia zlepšenie adas- cog najmenej o 4 body bez zhoršenia adcs- cgic a adcs- adl
itt-locf population at least 4 points improvement on adas-cog with no worsening on adcs- cgic and adcs-adl

Štúdia preukázala priaznivý účinok liečby memantínom v porovnaní s placebom po 6-tich mesiacov (analýza pozorovaných prípadov - významnosť rozdielov pre cibic-plus: p=0,025; pre adcs-adlsev: p=0,003; pre sib: p=0,002).
the study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician´s interview based impression of change (cibic-plus): p = 0.025; alzheimer´s disease cooperative study – activities of daily living (adcs-adlsev): p = 0.003; severe impairment battery (sib): p = 0.002).